Wegovy.com
(Denmark) – The makers of the weight-loss drug Wegovy will begin offering the drug directly to patients at a reduced cost.
Pharmaceutical company Novo Nordisk announced Wednesday (March 5, 2025) it’s starting NovoCare Pharmacy, a program that will offer direct-to-patient sales to underinsured or uninsured customers. The program will sell Wegovy for $499 per month to customers paying cash, an amount much less than the list price of over $1,300. This comes a week after Eli Lilly cut the price of its popular weight-loss drug Zepbound.
Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States.
